Correlation Between Kymera Therapeutics and Mirati Ther

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Mirati Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Mirati Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Mirati Ther, you can compare the effects of market volatilities on Kymera Therapeutics and Mirati Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Mirati Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Mirati Ther.

Diversification Opportunities for Kymera Therapeutics and Mirati Ther

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Kymera and Mirati is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Mirati Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirati Ther and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Mirati Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirati Ther has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Mirati Ther go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and Mirati Ther

Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 1.49 times more return on investment than Mirati Ther. However, Kymera Therapeutics is 1.49 times more volatile than Mirati Ther. It trades about 0.07 of its potential returns per unit of risk. Mirati Ther is currently generating about -0.21 per unit of risk. If you would invest  2,275  in Kymera Therapeutics on September 1, 2024 and sell it today you would earn a total of  2,410  from holding Kymera Therapeutics or generate 105.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy8.33%
ValuesDaily Returns

Kymera Therapeutics  vs.  Mirati Ther

 Performance 
       Timeline  
Kymera Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kymera Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable primary indicators, Kymera Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Mirati Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mirati Ther has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Mirati Ther is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Kymera Therapeutics and Mirati Ther Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kymera Therapeutics and Mirati Ther

The main advantage of trading using opposite Kymera Therapeutics and Mirati Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Mirati Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirati Ther will offset losses from the drop in Mirati Ther's long position.
The idea behind Kymera Therapeutics and Mirati Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges